Awen Oncology

Awen Oncology is a preclinical oncology drug developer dedicated to treating malignant tumors in the healthcare field. The company’s expertise in cellular biology, molecular biology, and chemistry combines translational structural biology with computational candidate drug screening to identify pharmacological agents, enabling clients to quickly and effectively determine new therapeutic targets and develop effective treatment methods.